Literature DB >> 15689649

A pilot study of feasibility and efficacy of telemedicine-delivered psychophysiological treatment for vascular headache.

John Arena1, Norwood Dennis, Trishul Devineni, Ross Maclean, Kimford Meador.   

Abstract

Headache is a common complaint. Psychological treatment has been effective in managing the symptoms of vascular (migraine and combined migraine-tension) headache. Traditional office-based treatment may be inconvenient for many patients in terms of time and travel constraints, thereby limiting access. Telemedicine has emerged as a promising delivery medium to address these barriers to access. However, the efficacy of remotely delivered treatment for vascular headache remains untested. This case series is a preliminary evaluation of effectiveness and feasibility of an analogue telemedicine system for delivery of psychophysiological treatment for vascular headache. Three of four subjects showed improvement. These findings are encouraging for follow-up study of the clinical utility and broader viability of headache treatment via distance technology.

Entities:  

Mesh:

Year:  2004        PMID: 15689649     DOI: 10.1089/tmj.2004.10.449

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  3 in total

Review 1.  Behavioral treatment of headaches: extending the reach.

Authors:  F Andrasik
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  Headache teleconsultation in the era of COVID-19: Patients' evaluation and future directions.

Authors:  Leonor Dias; Bárbara Martins; Maria João Pinto; Ana Luísa Rocha; Madalena Pinto; Andreia Costa
Journal:  Eur J Neurol       Date:  2021-06-09       Impact factor: 6.288

Review 3.  Electronic behavioral interventions for headache: a systematic review.

Authors:  Mia Tova Minen; John Torous; Jenelle Raynowska; Allison Piazza; Corita Grudzen; Scott Powers; Richard Lipton; Mary Ann Sevick
Journal:  J Headache Pain       Date:  2016-05-10       Impact factor: 7.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.